Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion type Assertion NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_head.
- NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion wasGeneratedBy ECO_0000203 NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_provenance.
- NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion wasDerivedFrom befree-20140225 NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_provenance.
- NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion SIO_000772 15668896 NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_provenance.
- NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion evidence source_evidence_literature NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_provenance.
- NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_assertion description "[Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816345.RAoiB77BIX-4F8RkbXNwsXoeBV6r5GzYasfy_EFTlsynY130_provenance.